Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?

The cannabinoid type-2 G protein-coupled (CB(2)) receptor is an emerging therapeutic target for pain management and immune system modulation. In a mouse model of Alzheimer’s disease (AD) the orally administered natural product 4′-O-methylhonokiol (MH) has been shown to prevent amyloidogenesis and pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gertsch, Jürg, Anavi-Goffer, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419612/
https://www.ncbi.nlm.nih.gov/pubmed/22716035
http://dx.doi.org/10.1186/1742-2094-9-135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419612/
https://www.ncbi.nlm.nih.gov/pubmed/22716035
http://dx.doi.org/10.1186/1742-2094-9-135

Ejemplares similares